A detailed history of Arizona State Retirement System transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 16,231 shares of CLDX stock, worth $538,869. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,231
Previous 15,906 2.04%
Holding current value
$538,869
Previous $667,000 10.04%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$32.76 - $42.56 $10,647 - $13,832
325 Added 2.04%
16,231 $600,000
Q1 2024

May 07, 2024

BUY
$35.22 - $51.88 $75,652 - $111,438
2,148 Added 15.61%
15,906 $667,000
Q4 2023

Jan 24, 2024

BUY
$22.61 - $40.65 $52,500 - $94,389
2,322 Added 20.3%
13,758 $545,000
Q3 2023

Nov 06, 2023

BUY
$25.45 - $37.46 $4,199 - $6,180
165 Added 1.46%
11,436 $314,000
Q2 2023

Aug 01, 2023

BUY
$30.29 - $38.28 $10,722 - $13,551
354 Added 3.24%
11,271 $382,000
Q1 2023

Apr 27, 2023

BUY
$34.78 - $47.43 $12,486 - $17,027
359 Added 3.4%
10,917 $392,000
Q4 2022

Feb 07, 2023

BUY
$27.78 - $45.38 $10,945 - $17,879
394 Added 3.88%
10,558 $470,000
Q3 2022

Nov 07, 2022

BUY
$22.7 - $37.57 $1,066 - $1,765
47 Added 0.46%
10,164 $286,000
Q2 2022

Jul 28, 2022

BUY
$20.5 - $37.33 $533 - $970
26 Added 0.26%
10,117 $273,000
Q1 2022

May 04, 2022

BUY
$27.64 - $39.32 $2,294 - $3,263
83 Added 0.83%
10,091 $344,000
Q4 2021

Feb 04, 2022

SELL
$35.68 - $56.27 $19,338 - $30,498
-542 Reduced 5.14%
10,008 $387,000
Q3 2021

Nov 12, 2021

SELL
$28.95 - $55.99 $5,934 - $11,477
-205 Reduced 1.91%
10,550 $570,000
Q2 2021

Aug 02, 2021

SELL
$20.71 - $35.37 $15,801 - $26,987
-763 Reduced 6.62%
10,755 $360,000
Q1 2021

May 06, 2021

BUY
$16.19 - $29.91 $2,768 - $5,114
171 Added 1.51%
11,518 $237,000
Q4 2020

Jan 28, 2021

BUY
$14.99 - $22.75 $170,091 - $258,144
11,347 New
11,347 $199,000

Others Institutions Holding CLDX

About Celldex Therapeutics, Inc.


  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.55B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.